BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38437062)

  • 1. Suppression of mitochondrial complex I influences cell metastatic properties.
    He X; Zhou A; Lu H; Chen Y; Huang G; Yue X; Zhao P; Wu Y
    PLoS One; 2013; 8(4):e61677. PubMed ID: 23630608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
    Dong L; Luo L; Wang Z; Lian S; Wang M; Wu X; Fan J; Zeng Y; Li S; Lv S; Yang Y; Chen R; Shen E; Yang W; Li C; Wang K
    Free Radic Biol Med; 2024 Apr; 220():111-124. PubMed ID: 38697493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis.
    Zhang Z; Zhao Q; Wang Z; Xu F; Liu Y; Guo Y; Li C; Liu T; Zhao Y; Tang X; Zhang J
    Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38437062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCU-dependent mitochondrial Ca
    Ren T; Zhang H; Wang J; Zhu J; Jin M; Wu Y; Guo X; Ji L; Huang Q; Zhang H; Yang H; Xing J
    Oncogene; 2017 Oct; 36(42):5897-5909. PubMed ID: 28650465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
    Sun J; Li P; Yang J
    Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
    Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
    Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
    Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation.
    Ren L; Meng L; Gao J; Lu M; Guo C; Li Y; Rong Z; Ye Y
    Cell Death Dis; 2023 Jan; 14(1):44. PubMed ID: 36658121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma.
    Zhou L; Mao LH; Li X; Wang QL; Chen SY; Chen ZJ; Lei J; Liu HT; Liao SQ; Ran T; Li XQ; Zhou ZH; He S
    Cancer Sci; 2023 Mar; 114(3):793-805. PubMed ID: 36369883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oocytes maintain ROS-free mitochondrial metabolism by suppressing complex I.
    Rodríguez-Nuevo A; Torres-Sanchez A; Duran JM; De Guirior C; Martínez-Zamora MA; Böke E
    Nature; 2022 Jul; 607(7920):756-761. PubMed ID: 35859172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ROS in tumour development and progression.
    Cheung EC; Vousden KH
    Nat Rev Cancer; 2022 May; 22(5):280-297. PubMed ID: 35102280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Relevance and Tumor Growth Suppression of Mitochondrial ROS Regulators along NADH:Ubiquinone Oxidoreductase Subunit B3 in Thyroid Cancer.
    Zhu J; Zheng X; Lu D; Zheng Y; Liu J
    Oxid Med Cell Longev; 2022; 2022():8038857. PubMed ID: 35087620
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.